# Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following BCS

> **NCT03710733** · NA · UNKNOWN · sponsor: **National Cancer Institute, Egypt** · enrollment: 185 (estimated)

## Conditions studied

- Radiotherapy Side Effect

## Interventions

- **RADIATION:** Sequential boost
- **RADIATION:** Concomitant boost

## Key facts

- **NCT ID:** NCT03710733
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 185 (ESTIMATED)
- **Last updated:** 2020-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03710733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03710733, "Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following BCS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03710733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*